Recent Quotes

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-04
REV		(EXPECTED)2021-08-04

Q1 2021		Est.		Actual		Surprise
EPS		-0.260		-0.190		0.0700
REV				0

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
BCLI	Brainstorm Cell	3.95	-0.01	-0.25%		143.5M

Brainstorm Cell Frequently Asked Questions

How do I buy Brainstorm Cell (BCLI) stock?

You can purchase shares of Brainstorm Cell (NASDAQ: BCLI) through any online brokerage.

View our list of the best stock brokerages.

Who are Brainstorm Cell's (BCLI) competitors?

Other companies in Brainstorm Cell’s space includes: Anixa Biosciences (NASDAQ:ANIX), Larimar Therapeutics (NASDAQ:LRMR), Calithera Biosciences (NASDAQ:CALA), NuCana (NASDAQ:NCNA) and GlycoMimetics (NASDAQ:GLYC).

What is the target price for Brainstorm Cell (BCLI) stock?

The latest price target for Brainstorm Cell (NASDAQ: BCLI) was reported by Maxim Group on February 5, 2021. The analyst firm set a price target for 0.00 expecting BCLI to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Brainstorm Cell (BCLI)?

The stock price for Brainstorm Cell (NASDAQ: BCLI) is $3.95 last updated Fri Jun 11 2021 20:00:03 GMT+0000 (Coordinated Universal Time).

Does Brainstorm Cell (BCLI) pay a dividend?

There are no upcoming dividends for Brainstorm Cell.

When is Brainstorm Cell (NASDAQ:BCLI) reporting earnings?

Brainstorm Cell’s Q2 earnings are confirmed for after-market on August 4, 2021.

Is Brainstorm Cell (BCLI) going to split?

There is no upcoming split for Brainstorm Cell.

What sector and industry does Brainstorm Cell (BCLI) operate in?

Brainstorm Cell is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.